Integra Average Inventory from 2010 to 2026
| IART Stock | USD 11.39 0.15 1.30% |
Average Inventory | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Check Integra LifeSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integra LifeSciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 169.7 M, Interest Expense of 85.3 M or Total Revenue of 1.9 B, as well as many indicators such as Price To Sales Ratio of 1.18, Dividend Yield of 3.0E-4 or PTB Ratio of 1.23. Integra financial statements analysis is a perfect complement when working with Integra LifeSciences Valuation or Volatility modules.
Integra | Average Inventory | Build AI portfolio with Integra Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.